What Is Lp(a)? The Cholesterol Test Your Doctor Probably Hasn't Ordered

If you've been seeing the term "Lp(a)" everywhere lately and feeling like you missed a memo — you didn't. The 2026 cholesterol guidelines just made this test a recommended standard for every adult, and most doctors are still catching up. Here's what it is, why it matters, and what to do with the result.

The 30-second version

Lp(a) — pronounced "L-P-little-a" — is a type of cholesterol particle in your blood. It's a lot like LDL, but with an extra protein attached that makes it more prone to causing trouble in your arteries. About 1 in 5 people have elevated Lp(a). Almost none of them know.

The level you're born with is the level you have for life. There's not much diet or exercise can do about it. But knowing your number changes everything about how the rest of your cholesterol picture should be managed.

Get tested. Once. Then you have the answer for the rest of your life.

How Lp(a) is different from LDL

If standard LDL is a fleet of delivery trucks moving cholesterol around your body, Lp(a) is the same kind of truck with a giant grappling hook welded to it. The hook makes it more likely to snag on artery walls. It also promotes blood clotting, which is a separate mechanism for triggering heart attacks and strokes.

The technical name for the hook is apolipoprotein(a) — apo(a) for short. It's structurally similar to a clotting protein called plasminogen, which is what gives Lp(a) its dual personality: artery damage on one side, clot promotion on the other. One particle, two ways to cause cardiovascular events.

Other key differences:

• Genetic. Lp(a) is roughly 80–90% inherited. Your level is set by the time you're a teenager and doesn't move much over the rest of your life.
• Stable. Diet, exercise, and weight loss barely move it. Stress doesn't move it. Your level today is essentially your level forever.
• Not on most lipid panels. A standard cholesterol test measures total cholesterol, LDL, HDL, and triglycerides. It does not measure Lp(a). You have to ask for it specifically.
• Independent of LDL. Your LDL can be perfect and your Lp(a) can be sky-high. Knowing one tells you almost nothing about the other.

Why it's been ignored — and why that's changing

Lp(a) was discovered in 1963. For decades, it sat in research papers because there was no drug that could lower it. Doctors don't routinely test for things they can't treat — that's a fair institutional reflex.

Two things changed in the past few years.

The data got overwhelming. Mendelian randomization studies — which use genetics to test causation — established that Lp(a) doesn't just correlate with heart disease, it causes it. The relationship is dose-dependent: higher Lp(a), higher risk, in a clean linear way.

The drugs are coming. Several pharmaceutical companies — Novartis, Amgen, Eli Lilly — are running phase 3 trials on Lp(a)-lowering drugs. Early results show single injections cutting Lp(a) by 90% or more, with effects lasting months. The first FDA approval is expected within the next few years.

Both factors converged in March 2026, when the American College of Cardiology and American Heart Association issued new dyslipidemia guidelines that include — for the first time — a Class I recommendation for one-time Lp(a) testing in every adult. That's the strongest level of recommendation in the guidelines.

If your doctor hasn't mentioned it yet, they will. Or you can mention it first.

What "high" Lp(a) means

Lp(a) is reported in two different units, which causes a lot of confusion. Either is fine:

• mg/dL (the older unit, common in US labs)
• nmol/L (the newer, more accurate unit)

Rough thresholds:

• Below 30 mg/dL (75 nmol/L) — normal
• 30–50 mg/dL (75–125 nmol/L) — borderline
• 50–100 mg/dL (125–250 nmol/L) — high (about 20% of people)
• 100+ mg/dL (250+ nmol/L) — very high (roughly 5–10% of people)

If you're above 50, your cardiovascular risk is meaningfully elevated independent of your LDL. If you're above 100, the elevation is significant and your other risk factors need to be managed more aggressively.

What to do if your Lp(a) is high

The frustrating part: you can't currently lower Lp(a) with diet or lifestyle in any meaningful way. The useful part: knowing your number sharpens every other lever you do have.

Get your LDL much lower

If your Lp(a) is high, the case for keeping LDL aggressively low (under 70 or even under 55 mg/dL) becomes much stronger. The two particles compound each other — high Lp(a) on top of high LDL is meaningfully worse than either alone. Lowering LDL doesn't fix Lp(a), but it removes one of the two stacked risks.

This is often the moment when a doctor moves a patient onto a statin (or statin + ezetimibe) even when the LDL number alone wouldn't have triggered medication.

Tighten everything else

Blood pressure should be optimal. No smoking. Move toward a 25 BMI. Lower your apoB (the count of all atherogenic particles, not just LDL — we cover apoB here). Exercise. The "small" lifestyle factors compound when Lp(a) is loaded.

Tell your family

Lp(a) is inherited. If yours is high, your siblings and children likely have elevated Lp(a) too. Tell them. They should get tested. Most won't unless someone they trust mentions it.

Keep an eye on the new drugs

Pelacarsen (Novartis) and olpasiran (Amgen) are leading the field in late-stage trials. Both inject monthly or less often, both lower Lp(a) by 80–95%. If approved, they'll likely be expensive at first and reserved for people with very high Lp(a) and other risk factors. But they're coming.

Niacin (probably not)

High-dose niacin lowers Lp(a) by about 25%. It also lowers HDL slightly and has uncomfortable side effects (flushing, GI distress). Most cardiologists don't recommend niacin specifically for Lp(a) anymore — the side effects aren't worth the modest benefit. If you've read about niacin online and are considering it, talk to your doctor first.

What if your Lp(a) is normal?

Genuinely good news. About 80% of people will fall in this category. You can ignore Lp(a) for the rest of your life — it's a stable number and you've ruled out a major hidden risk factor.

The reason universal testing is recommended despite most people being fine: the 20% who aren't fine usually don't know it. The cost of testing everyone once is small compared to the cost of missing the people whose Lp(a) is dangerously high.

How to actually get tested

Three options, in increasing convenience:

1. Ask your doctor. At your next physical or cholesterol follow-up, just ask: "Can we add an Lp(a) test to my order?" If they hesitate, mention it's now a Class I recommendation in the 2026 ACC/AHA guidelines. Most will agree.
2. Direct-to-consumer labs. Quest, Labcorp, Marek Health, and others let you order your own tests. Costs $30–$70. You get results in a few days.
3. Cardiologist or preventive cardiology clinic. If you're already in this system because of high LDL, family history, or other risk factors, they almost certainly include Lp(a) in their standard workup.

Whatever route you take: you only need to do it once. Save the result somewhere you'll find it in 20 years.

Frequently asked questions

What's a normal Lp(a) level?

Below 30 mg/dL (or 75 nmol/L). About 80% of adults fall in this range and never need to think about Lp(a) again.

Should kids get tested for Lp(a)?

Increasingly, yes — especially if a parent has high Lp(a) or a family history of early heart disease. Most pediatric guidelines now suggest testing once in childhood or adolescence so that risk can be managed proactively.

Does Lp(a) ever go up over time?

Slightly, in some people, especially after menopause. But the change is small enough that a one-time adult test is sufficient for almost everyone. If yours is borderline, retesting in 5–10 years is reasonable.

Can pregnancy affect Lp(a)?

Yes, slightly — it tends to be higher during pregnancy. If you're pregnant or recently postpartum, wait a few months before testing for the most representative number.

What if my Lp(a) is high but my LDL is normal?

You're not unusual. About 1 in 5 people have this profile. The mainstream cholesterol panel makes you look fine; you actually have elevated cardiovascular risk. This is why testing matters. Talk to your doctor about whether to lower LDL even more aggressively (often the answer is yes), and have your other risk factors checked carefully.

Will the new Lp(a) drugs be available soon?

The first phase 3 trials read out in 2025-2026. FDA approval likely in 2027–2028 if the data hold. Initial cost will be high (these are biologics). Insurance coverage will follow eventually if cardiovascular outcome data is strong. Worth tracking but not worth waiting for if you have other risk factors today.

Hey Heart is a calm, photo-based saturated fat tracker for people who want to take their heart health seriously without obsessing. Learn more →

Hey Heart is a wellness app and not a medical device. The information in this article is general guidance only and is not medical advice, diagnosis, or treatment. Always consult your doctor about your specific health situation.